Zeria Pharmaceutical Co Ltd banner

Zeria Pharmaceutical Co Ltd
TSE:4559

Watchlist Manager
Zeria Pharmaceutical Co Ltd Logo
Zeria Pharmaceutical Co Ltd
TSE:4559
Watchlist
Price: 2 148 JPY 4.17%
Market Cap: ¥94.7B

Net Margin

6.6%
Current
Declining
by 3.2%
vs 3-y average of 9.8%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
6.6%
=
Net Income
¥5.6B
/
Revenue
¥84.8B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
6.6%
=
Net Income
¥5.6B
/
Revenue
¥84.8B

Peer Comparison

Country Company Market Cap Net
Margin
JP
Zeria Pharmaceutical Co Ltd
TSE:4559
94.7B JPY
Loading...
US
Eli Lilly and Co
NYSE:LLY
964.4B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
572.6B USD
Loading...
CH
Roche Holding AG
SIX:ROG
284.3B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
297.7B USD
Loading...
CH
Novartis AG
SIX:NOVN
228.8B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
217.7B GBP
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK
Loading...
US
Pfizer Inc
NYSE:PFE
151.1B USD
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
120.9B USD
Loading...

Market Distribution

In line with most companies in Japan
Percentile
59th
Based on 6 917 companies
59th percentile
6.6%
Low
-122 700% — 2.9%
Typical Range
2.9% — 8.5%
High
8.5% — 63 031.4%
Distribution Statistics
Japan
Min -122 700%
30th Percentile 2.9%
Median 5.4%
70th Percentile 8.5%
Max 63 031.4%

Zeria Pharmaceutical Co Ltd
Glance View

Market Cap
94.7B JPY
Industry
Pharmaceuticals

Zeria Pharmaceutical Co., Ltd. engages in the manufacture, sale, import and export of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 1,690 full-time employees. The firm operates in two business segments. The Ethical Drug segment is engaged in the research, development, manufacture and sale of ethical drugs. The Consumer Healthcare segment is engaged in the manufacture, purchase and sale of over-the-counter (OTC) drugs, health foods, quasi drugs and cosmetics related to self-medication. The others include insurance agency business and real estate business, as well as various maintenance business such as purchasing and sale of promotional materials.

Intrinsic Value
3 992.5 JPY
Undervaluation 46%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
6.6%
=
Net Income
¥5.6B
/
Revenue
¥84.8B
What is Zeria Pharmaceutical Co Ltd's current Net Margin?

The current Net Margin for Zeria Pharmaceutical Co Ltd is 6.6%, which is below its 3-year median of 9.8%.

How has Net Margin changed over time?

Over the last 3 years, Zeria Pharmaceutical Co Ltd’s Net Margin has decreased from 9% to 6.6%. During this period, it reached a low of 6.6% on Oct 30, 2025 and a high of 11.6% on Dec 31, 2023.

Back to Top